30% OFF your first order, Free Shipping Over $175
BPC-157, also known as Body Protection Compound 157, is a synthetic research peptide derived from a naturally occurring gastric protein sequence. It is widely studied in regenerative peptide research for its relevance in tissue signaling, angiogenic activity, vascular response, and extracellular matrix support.
Preclinical research continues to explore how BPC-157 interacts with cellular repair pathways associated with connective tissue, gastrointestinal environments, inflammatory response models, and structural tissue integrity. Its stability and broad investigational relevance have made BPC-157 one of the most recognized compounds in laboratory studies involving peptide signaling, tissue remodeling, and regenerative research.
Research interest often includes connective tissue, inflammatory response pathways, and cellular repair environments.
Store lyophilized BPC-157 at -20°C. After reconstitution, refrigerate according to research handling guidance.
BPC-157 is commonly studied in research models involving tissue response, cellular repair signaling, and recovery-focused laboratory pathways.
No. BPC-157 is intended for laboratory and research purposes only.
Review the product batch details and Certificate of Analysis where available for purity and identity information.
BPC-157 is typically supplied as lyophilized powder for controlled laboratory research use.
Every batch we supply is handled with clear documentation, quality-focused standards, and research-use transparency for laboratories that need dependable product information.
Products are presented with laboratory-focused specifications and clear handling details.
Certificate and batch details help support review before research handling.
Checkout, packaging, and order handling are built for a clean ecommerce experience.
All products are intended strictly for laboratory and research purposes only.
By subscribing, you agree to receive marketing texts & emails from Clarus Peptides. Msg & data rates may apply. Reply STOP to opt out
